EP‐181
EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Jörg Sievers, Choy Man, Rimgaile Urbaityte, Mark Underwood, Jean Andre Van Wyk, Kimberly Smith, Roberto Zajdenverg
GlaxoSmithKline (GSK), Brasil
Read
6060
Timeswas read the article
1656
Total PDF
4404
Total HTML
Article information
ISSN: 14138670Original language: Portuguese
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 58 | 3 | 61 |
| 2025 5 | 231 | 42 | 273 |
| 2025 4 | 222 | 30 | 252 |
| 2025 3 | 265 | 28 | 293 |
| 2025 2 | 166 | 29 | 195 |
| 2025 1 | 206 | 30 | 236 |
| 2024 12 | 204 | 21 | 225 |
| 2024 11 | 296 | 23 | 319 |
| 2024 10 | 309 | 30 | 339 |
| 2024 9 | 197 | 19 | 216 |
| 2024 8 | 132 | 26 | 158 |
| 2024 7 | 84 | 33 | 117 |
| 2024 6 | 72 | 26 | 98 |
| 2024 5 | 77 | 37 | 114 |
| 2024 4 | 94 | 31 | 125 |
| 2024 3 | 121 | 30 | 151 |
| 2024 2 | 100 | 38 | 138 |
| 2024 1 | 67 | 39 | 106 |
| 2023 12 | 49 | 28 | 77 |
| 2023 11 | 70 | 55 | 125 |
| 2023 10 | 41 | 33 | 74 |
| 2023 9 | 64 | 34 | 98 |
| 2023 8 | 51 | 27 | 78 |
| 2023 7 | 37 | 22 | 59 |
| 2023 6 | 37 | 13 | 50 |
| 2023 5 | 37 | 24 | 61 |
| 2023 4 | 28 | 8 | 36 |
| 2023 3 | 58 | 34 | 92 |
| 2023 2 | 41 | 25 | 66 |
| 2023 1 | 42 | 13 | 55 |
| 2022 12 | 52 | 27 | 79 |
| 2022 11 | 98 | 35 | 133 |
| 2022 10 | 83 | 24 | 107 |
| 2022 9 | 67 | 39 | 106 |
| 2022 8 | 66 | 35 | 101 |
| 2022 7 | 61 | 46 | 107 |
| 2022 6 | 41 | 35 | 76 |
| 2022 5 | 36 | 37 | 73 |
| 2022 4 | 45 | 40 | 85 |
| 2022 3 | 34 | 47 | 81 |
| 2022 2 | 44 | 37 | 81 |
| 2022 1 | 35 | 26 | 61 |
| 2021 12 | 40 | 44 | 84 |
| 2021 11 | 31 | 37 | 68 |
| 2021 10 | 33 | 31 | 64 |
| 2021 9 | 32 | 32 | 64 |
| 2021 8 | 19 | 30 | 49 |
| 2021 7 | 16 | 15 | 31 |
| 2021 6 | 22 | 34 | 56 |
| 2021 5 | 32 | 48 | 80 |
| 2021 4 | 45 | 105 | 150 |
| 2021 3 | 16 | 21 | 37 |
Show all
